Everolimus BSA Conjugate from Molecular Depot

SAN DIEGO - March 1, 2020 - PRLog -- Molecular Depot introduces the first commercially available Everolimus BSA conjugate.
The product consists of a concentrated solution of Bovine Serum Albumin (BSA) conjugated to Everolimus. A carbon spacer arm of 19.0 Å links BSA to the Everolimus moiety. Each BSA molecule contains several Everolimus units. Dilutions of the provided conjugate can be made in 1X Phosphate Buffer Saline, pH 7.4.

Product
Catalog number:  P2010024
Lot number:  0120P0024
Expiration date:  2024-02
Purity:  > 95%
Concentration:  1 mg/mL
Package Size:  0.5 mg
Molecular Weight:  71 kDa (average)
Storage:  -20°C. Avoid repeated freeze/thaw cycles.
Other names:  BSA-Everolimus, Everolimus-BSA, BSA conjugated to Everolimus, 40-O-(2-hydroxyethyl)-sirolimus BSA, Everolimus Bovine Serum Albumin Conjugate, Everolimus [BSA].
Keywords:  BSA conjugate, Everolimus, Certican, Zortress, Afinitor, Votubia, Evertor.
Buffer:  1X Phosphate Buffer Saline, pH 7.4.

About Everolimus
Everolimus is a synthetic derivative of the natural compound sirolimus (40-O-(2-hydroxyethyl)-sirolimus). Everolimus has both immunosuppressant and anti-angiogenic properties. As a result, this molecule finds several applications in organ transplant as well as chemotherapy. Inside the cell, Everolimus inhibits the activation of the mammalian target of Rapamycin (sirolimus) (mTOR).

More Information
Please visit https://moleculardepot.com/product/everolimus-bsa-conjugate/